Standard Biotools (LAB) Net Cash Flow Growth (5y) (2015 - 2026)
Standard Biotools (LAB) Net Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.02 Bn | 179.73 Bn | 6.27 Bn |
| 2 | Stryker | 132.07 Bn | 129.19 Bn | 3.81 Bn |
| 3 | Medtronic | 111.38 Bn | 102.16 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.98 Bn | 67.53 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn |
| 6 | Dexcom | 28.91 Bn | 27.80 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.83 Bn | 26.55 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 28.10 Bn | 27.52 Bn | - |
| 9 | Koninklijke Philips | 24.30 Bn | 21.26 Bn | 2.01 Bn |
| 10 | Standard Biotools | 302.10 Mn | -153.08 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.41% |
| Dec 31, 2025 | -15.87% |
| Sep 30, 2025 | -24.56% |
| Jun 30, 2025 | -2.41% |
| Mar 31, 2025 | -26.51% |
| Dec 31, 2024 | -58.48% |
| Sep 30, 2024 | -102.77% |
| Jun 30, 2024 | 15.37% |
| Mar 31, 2024 | 58.27% |
| Dec 31, 2023 | -19.87% |
| Sep 30, 2023 | -78.99% |
| Jun 30, 2023 | 71.75% |
| Mar 31, 2023 | 31.60% |
| Dec 31, 2022 | 54.65% |
| Sep 30, 2022 | -21.53% |
| Jun 30, 2022 | 62.75% |
| Mar 31, 2022 | -29.08% |
| Sep 30, 2021 | -62.61% |
| Jun 30, 2021 | -40.40% |
| Mar 31, 2021 | -27.77% |